Menu
Currency
GWAS Study

Genome-wide association meta-analysis yields 20 loci associated with gallstone disease.

Ferkingstad E, Oddsson A, Gretarsdottir S et al.

30504769 PubMed ID
GWAS Study Type
764012 Participants
72 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FE
Ferkingstad E
OA
Oddsson A
GS
Gretarsdottir S
BS
Benonisdottir S
TG
Thorleifsson G
DA
Deaton AM
JS
Jonsson S
SO
Stefansson OA
NG
Norddahl GL
ZF
Zink F
AG
Arnadottir GA
GB
Gunnarsson B
HG
Halldorsson GH
HA
Helgadottir A
JB
Jensson BO
KR
Kristjansson RP
SG
Sveinbjornsson G
SD
Sverrisson DA
MG
Masson G
OI
Olafsson I
EG
Eyjolfsson GI
SO
Sigurdardottir O
HH
Holm H
JI
Jonsdottir I
OS
Olafsson S
ST
Steingrimsdottir T
RT
Rafnar T
BE
Bjornsson ES
TU
Thorsteinsdottir U
GD
Gudbjartsson DF
SP
Sulem P
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Gallstones are responsible for one of the most common diseases in the Western world and are commonly treated with cholecystectomy. We perform a meta-analysis of two genome-wide association studies of gallstone disease in Iceland and the UK, totaling 27,174 cases and 736,838 controls, uncovering 21 novel gallstone-associated variants at 20 loci. Two distinct low frequency missense variants in SLC10A2, encoding the apical sodium-dependent bile acid transporter (ASBT), associate with an increased risk of gallstone disease (Pro290Ser: OR = 1.36 [1.25-1.49], P = 2.1 × 10-12, MAF = 1%; Val98Ile: OR = 1.15 [1.10-1.20], P = 1.8 × 10-10, MAF = 4%). We demonstrate that lower bile acid transport by ASBT is accompanied by greater risk of gallstone disease and highlight the role of the intestinal compartment of the enterohepatic circulation of bile acids in gallstone disease susceptibility. Additionally, two low frequency missense variants in SERPINA1 and HNF4A and 17 common variants represent novel associations with gallstone disease.

27,174 European ancestry cases, 736,838 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

764012
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K., Iceland
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.